[Intestinal lymphagiectasis. Use of immunoregulators].
The authors present a patient with intestinal lymphangiectasis discussing the pathophysiology, diagnosis and immunologic treatment instituted which was with mebendazole, sulfazalosopyridine and oral calcium. Immunoglobulins and T and B leukocytes showed increase together with clinical improvement in the diarrheal picture.
D001562:Benzimidazoles / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D008201:Lymphangiectasis, Intestinal / Q000000981:diagnostic imaging / Q000178:diet therapy / Q000188:drug therapy*; D008297:Male; D008463:Mebendazole / Q000627:therapeutic use*; D011504:Protein-Losing Enteropathies / Q000188:drug therapy*; D011859:Radiography; D013424:Sulfanilamides / Q000627:therapeutic use*; D013427:Sulfapyridine / Q000627:therapeutic use*
D001562:Benzimidazoles; D007166:Immunosuppressive Agents; D013424:Sulfanilamides; D008463:Mebendazole; D013427:Sulfapyridine
Linfangiectasia intestinal. Uso de inmunorreguladores.